BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21168163)

  • 1. Editorial comment.
    Penson DF
    J Urol; 2011 Feb; 185(2):413-4; author reply 414. PubMed ID: 21168163
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Cost NG; Margulis V
    J Urol; 2011 Feb; 185(2):413; author reply 414. PubMed ID: 21168168
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with small renal masses: a survey of the American Urological Association.
    Breau RH; Crispen PL; Jenkins SM; Blute ML; Leibovich BC
    J Urol; 2011 Feb; 185(2):407-13. PubMed ID: 21168170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Matthew N. Simmons, Benjamin I. Chung, Inderbir S. Gill. Perioperative efficacy of laparoscopic partial nephrectomy for tumors larger than 4 cm. Eur Urol 2009;55:199-208.
    Baumert H
    Eur Urol; 2009 Jun; 55(6):e103; author reply e104. PubMed ID: 19249152
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding the indications of partial nephrectomy.
    Rogers CG
    Eur Urol; 2011 Jun; 59(6):938-9. PubMed ID: 21440982
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Autorino R; Falsaperla M
    Eur Urol; 2009 Jun; 55(6):1408. PubMed ID: 19299070
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
    Terrone C
    Eur Urol; 2010 Jan; 57(1):120-1. PubMed ID: 19406566
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
    Zigeuner R
    Eur Urol; 2010 Jan; 57(1):121-2. PubMed ID: 19406564
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
    Goldfarb DA
    J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Patel HR
    Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer of the kidney in adults. Treatment of the localized stage].
    Prog Urol; 1997 Nov; 7(5):843-57. PubMed ID: 9458482
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 16. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Blute ML
    Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Giannarini G; Autorino R
    Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoma of the kidney in the adult: results of current treatment. 120 cases (author's transl)].
    Cukier J; Amiel JL; Bronstein M; Droz JP
    Nouv Presse Med; 1979 Jan; 8(5):319-21. PubMed ID: 554090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.